Key result
The rank order of potency for evoking the pulmonary chemoreflex was 5-HT > PBG > PG > PDG, with all responses antagonized by the 5-HT3 receptor antagonist MDL 72222.
Why the study?
Do phenylbiguanide, phenyldiguanide, phenylguanidine, and 5-hydroxytryptamine evoke the pulmonary chemoreflex via 5-HT3 receptors in anaesthetized rabbits?
Do phenylbiguanide, phenyldiguanide, phenylguanidine, and 5-hydroxytryptamine evoke the pulmonary chemoreflex via 5-HT3 receptors in anaesthetized rabbits?
Phenylbiguanide, not phenyldiguanide, is the appropriate agonist for identifying non-myelinated pulmonary vagal afferents and evoking the pulmonary chemoreflex via 5-HT3 receptors in rabbits.
Answers are grounded in this paper and cite their sources.
PBG preferred over PDG for 5-HT3 pulmonary chemoreflex studies in rabbits; extends agonist characterization but leaves translation open.
The pulmonary chemoreflexes evoked by phenylbiguanide (PBG), phenyldiguanide (PDG), phenylguanidine (PG) and 5-hydroxytryptamine (5-HT) have been investigated in the pentobarbitone-anaesthetized rabbit. The rank order of potency was 5-HT greater than PBG greater than PG greater than PDG. The responses evoked by all agonists were antagonized by pre-treatment with the selective 5-HT3 receptor antagonist MDL 72222, suggesting that their reflex effects are mediated by 5-HT3 receptors located on pulmonary vagal afferents. Furthermore, considering the low potency and long injection response time of PDG compared to PBG, we conclude that previous workers have used PBG and not PDG to identify non-myelinated pulmonary vagal afferents and to evoke the pulmonary chemoreflex.
No takes yet. Share an insight, caveat, or question.
Kay et al. (1990) studied this question. Phenylbiguanide (PBG), phenyldiguanide (PDG), phenylguanidine (PG) and 5-hydroxytryptamine (5-HT) was evaluated on Pulmonary chemoreflex potency and response to 5-HT3 receptor antagonist MDL 72222. The rank order of potency for evoking the pulmonary chemoreflex was 5-HT > PBG > PG > PDG, with all responses antagonized by the 5-HT3 receptor antagonist MDL 72222.
Synapse has enriched 10 related papers. Consider them for comparative context: